Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prothena Corp (NQ: PRTA ) 20.77 -0.10 (-0.48%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Prothena Corp < Previous 1 2 3 4 5 6 7 Next > 4 Analysts Have This to Say About Prothena Corp December 18, 2023 Via Benzinga Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others November 21, 2023 Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this Via Benzinga Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning November 17, 2023 Biotech companies are edging closer to finding the answers behind Alzheimer's disease. Via Investor's Business Daily 8 Health Care Stocks Whale Activity In Today's Session November 07, 2023 Via Benzinga Prothena Reports Third Quarter 2023 Financial Results and Business Highlights November 02, 2023 From Prothena Corporation plc Via Business Wire Earnings Preview For Prothena Corp November 01, 2023 Via Benzinga Expert Ratings for Prothena Corp October 23, 2023 Via Benzinga Expert Ratings for Prothena Corp August 22, 2023 Via Benzinga Prothena to Report Third Quarter 2023 Financial Results on November 2 October 26, 2023 From Prothena Corporation plc Via Business Wire Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment October 26, 2023 Both companies are working on under-the-skin injections for Alzheimer's treatment. Via Investor's Business Daily Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday October 16, 2023 U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities JMP Securities Maintains Outperform Rating for Prothena Corp: Here's What You Need To Know August 04, 2023 Via Benzinga Earnings Scheduled For August 3, 2023 August 03, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. Via Benzinga Prothena Corp's Earnings Outlook August 02, 2023 Via Benzinga Expert Ratings for Prothena Corp July 11, 2023 Via Benzinga 8 Analysts Have This to Say About Prothena Corp June 21, 2023 Via Benzinga Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 16, 2023 Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday. Via Benzinga Why Is Alzheimer's Player Prothena Stock Trading Higher Today? October 16, 2023 Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale. Via Benzinga Looking Into Prothena Corp's Return On Capital Employed May 16, 2023 Via Benzinga Recap: Prothena Corp Q1 Earnings May 04, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Thursday October 05, 2023 On Thursday, 369 companies hit new 52-week lows. Via Benzinga Prothena to Participate in Upcoming Healthcare Conferences August 31, 2023 From Prothena Corporation plc Via Business Wire Prothena Reports Second Quarter 2023 Financial Results and Business Highlights August 03, 2023 From Prothena Corporation plc Via Business Wire Prothena to Report Second Quarter 2023 Financial Results on August 3 July 27, 2023 From Prothena Corporation plc Via Business Wire Prothena Presents New Research in the Treatment of Alzheimer’s Disease at Alzheimer’s Association International Conference® 2023 (AAIC®) July 17, 2023 From Prothena Corporation plc Via Business Wire Prothena to Present New Data from Alzheimer’s Disease Programs at Alzheimer’s Association International Conference® 2023 (AAIC®) July 11, 2023 From Prothena Corporation plc Via Business Wire Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody July 10, 2023 From Prothena Corporation plc Via Business Wire Prothena Announces Phase 3 VITAL Clinical Trial Results Published in Blood Showing Survival Benefit in Patients with Mayo Stage IV AL Amyloidosis Treated with Birtamimab June 27, 2023 From Prothena Corporation plc Via Business Wire Prothena to Participate in Jefferies 2023 Healthcare Conference June 02, 2023 From Prothena Corporation plc Via Business Wire Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors May 16, 2023 From Prothena Corporation plc Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.